Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CES2 | O00748 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22497321 | 1.00 | THRB (0.54) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL31106045 | 1.00 | THRB (0.54) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL25298734 | 1.00 | THRB (0.54) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL25242882 | 1.00 | THRB (0.54) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL23567292 | 0.97 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL11048788 | 0.97 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL723818 | 0.97 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL23567250 | 0.97 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL15842210 | 0.97 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL23567212 | 0.97 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114380673-B | Dialkoxy alkenyl alkoxy methyl ether compound and method for preparing terminal conjugated alkadiene aldehyde compound from same | 信越化学工业株式会社 | 2024-09-13 | — | — | CN | disclosed |
| US-12060323-B2 | 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-08-13 | — | — | US | disclosed |
| US-20230312454-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| EP-3978465-B1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | SHINETSU CHEMICAL CO (JP) | 2023-06-14 | — | — | EP | disclosed |
| EP-3885334-B1 | PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME | SHINETSU CHEMICAL CO (JP) | 2023-01-11 | — | — | EP | disclosed |
| CN-114380669-A | 6-hydroxy-3-hexenylalkoxymethyl ether compounds and process for preparing 3, 13-octadecadien-1-ol therefrom | 信越化学工业株式会社 | 2022-04-22 | — | — | CN | disclosed |
| US-20220106252-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-04-07 | — | — | US | disclosed |
| EP-3885334-A1 | PROCESS FOR PREPARING A FORMYLALKENYL ALKOXYMETHYL ETHER COMPOUND AND PROCESSES FOR PREPARING CONJUGATED DIENE COMPOUNDS FROM THE SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-09-29 | — | — | EP | disclosed |
| US-7132252-B2 | Comprises fluorophores selected from 7-hydroxycoumarin derivtives, resorufin, and a fluorescein; drug screening | INVITROGEN CORPORATION (US) | 2006-11-07 | — | — | US | disclosed |
| US-6638713-B2 | Measurement of cytochrome enzymatic activity; obtain sample containing cytochrome, incubate with labeled substrate, monitor adjustments in optical signal, compare to control, quantify | AURORA BIOSCIENCES CORPORATION | 2003-10-28 | — | — | US | disclosed |
| US-20030186349-A1 | Optical molecular sensors for cytochrome P450 activity | Life Technologies Corporation | 2003-10-02 | — | — | US | disclosed |
| EP-1140888-B1 | OPTICAL MOLECULAR SENSORS FOR CYTOCHROME P450 ACTIVITY | VERTEX PHARMA SAN DIEGO LLC (US) | 2003-05-14 | — | — | EP | disclosed |
| US-20030027238-A1 | Optical molecular sensors for cytochrome P450 activity | Life Technologies Corporation | 2003-02-06 | — | — | US | disclosed |
| US-6514687-B1 | Screening a candidate compound for activity as a Cytochrome P450 enzyme substrate by contacting the compound, enzyme, and a reagent chromogen comprising the ether of a phenolic dye such as a coumarin, resofurin or fluorescein dye | VERTEX PHARMACEUTICALS (SAN DIEGO), LLC | 2003-02-04 | — | — | US | disclosed |
| US-6420130-B1 | CHEMICAL COMPOUND FOR USE IN THE DETECTION OF PREFERENTIAL ENZYMATIC POLYPEPTIDE | AURORA BIOSCIENCES CORPORATION | 2002-07-16 | — | — | US | disclosed |
| EP-1140888-A1 | OPTICAL MOLECULAR SENSORS FOR CYTOCHROME P450 ACTIVITY | Aurora Biosciences Corporation (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035900-A1 | OPTICAL MOLECULAR SENSORS FOR CYTOCHROME P450 ACTIVITY | AURORA BIOSCIENCES CORPORATION (US) | 2000-06-22 | — | — | WO | disclosed |
| US-4568700-A | NONCARCINOGEN | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1986-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12060323-B2 | 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same | CYP8B1, CYP2E1, OXER1 | THRB 2934/4885HTT 2747/4885MEN1 2297/4885 |
| US-20230312454-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | CYP8B1, CYP2E1, OXER1 | THRB 3019/4885HTT 2815/4885MEN1 2324/4885 |
| US-20220106252-A1 | 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME | CYP8B1, OXER1, CYP2E1 | THRB 3093/4885HTT 2553/4885MEN1 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.